AU5103096A - Use of ferrites for determining the perfusion of human tissue by m.r. diagnosis - Google Patents

Use of ferrites for determining the perfusion of human tissue by m.r. diagnosis

Info

Publication number
AU5103096A
AU5103096A AU51030/96A AU5103096A AU5103096A AU 5103096 A AU5103096 A AU 5103096A AU 51030/96 A AU51030/96 A AU 51030/96A AU 5103096 A AU5103096 A AU 5103096A AU 5103096 A AU5103096 A AU 5103096A
Authority
AU
Australia
Prior art keywords
ferrites
perfusion
diagnosis
determining
human tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU51030/96A
Inventor
Thomas Balzer
Andreas Muhler
Peter Reimer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer Pharma AG
Original Assignee
Schering AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering AG filed Critical Schering AG
Publication of AU5103096A publication Critical patent/AU5103096A/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Radiology & Medical Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Signal Processing (AREA)
  • Epidemiology (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Condensed Matter Physics & Semiconductors (AREA)
  • General Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU51030/96A 1995-03-08 1996-03-07 Use of ferrites for determining the perfusion of human tissue by m.r. diagnosis Abandoned AU5103096A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19509694A DE19509694A1 (en) 1995-03-08 1995-03-08 Use of magnetites to determine the perfusion of human tissue using MR diagnostics
DE9509694 1995-03-08
PCT/EP1996/000967 WO1996027394A1 (en) 1995-03-08 1996-03-07 Use of ferrites for determining the perfusion of human tissue by m.r. diagnosis

Publications (1)

Publication Number Publication Date
AU5103096A true AU5103096A (en) 1996-09-23

Family

ID=7756943

Family Applications (1)

Application Number Title Priority Date Filing Date
AU51030/96A Abandoned AU5103096A (en) 1995-03-08 1996-03-07 Use of ferrites for determining the perfusion of human tissue by m.r. diagnosis

Country Status (5)

Country Link
AU (1) AU5103096A (en)
DE (1) DE19509694A1 (en)
IL (1) IL117372A0 (en)
WO (1) WO1996027394A1 (en)
ZA (1) ZA961919B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60035127T2 (en) 2000-03-06 2008-02-14 Dade Behring Marburg Gmbh POLYSACCHARIDE-COATED CARRIER, THEIR MANUFACTURE AND USE
US7082326B2 (en) 2000-03-31 2006-07-25 Amersham Health As Method of magnetic resonance imaging
WO2001074245A1 (en) * 2000-03-31 2001-10-11 Amersham Health As Method of magnetic resonance imaging
DE10046514A1 (en) * 2000-09-15 2002-04-25 Diagnostikforschung Inst Process for imaging and diagnosis of thrombi using magnetic resonance imaging using particulate contrast media
US6690962B2 (en) 2000-09-15 2004-02-10 Institut fur Diagnostikforshung GmbH Process for graphic visualization and diagnosis of thrombi by means of nuclear spin tomography with use of particulate contrast media
FR2861994A1 (en) * 2003-11-12 2005-05-13 Guerbet Sa Using coated magnetic oxide particles for diagnosis or treatment of diseases in which matrix metalloproteases are implicated e.g. atheromous plaque or cancers, do not include targeting agent

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT81498B (en) * 1984-11-23 1987-12-30 Schering Ag METHOD FOR PREPARING COMPOSITIONS FOR DIAGNOSTICS CONTAINING MAGNETIC PARTICLES
DE3443251C2 (en) * 1984-11-23 1998-03-12 Schering Ag Iron oxide complexes for NMR diagnosis, diagnostic compounds containing these compounds, their use and process for their preparation
US5055288A (en) * 1987-06-26 1991-10-08 Advanced Magnetics, Inc. Vascular magnetic imaging method and agent comprising biodegradeable superparamagnetic metal oxides
DE10199065I2 (en) * 1991-01-19 2004-09-23 Meito Sangyo Kk The composition contains ultrafine magnetic metal oxide particles
ATE161546T1 (en) * 1991-06-11 1998-01-15 Meito Sangyo Kk OXIDIZED COMPOSITION CONTAINING A WATER SOLUBLE CARBOXYPOLYSACCHARIDE AND MAGNETIC IRON OXIDE

Also Published As

Publication number Publication date
ZA961919B (en) 1996-07-16
IL117372A0 (en) 1996-07-23
WO1996027394A1 (en) 1996-09-12
DE19509694A1 (en) 1996-09-19

Similar Documents

Publication Publication Date Title
AU1683797A (en) Medical diagnostic analysis system
AU7112396A (en) Surgical/diagnostic imaging device
AU5312496A (en) Partially disposable surgical imaging assembly
EP0629994A3 (en) Micro-grooves for the design of wideband clinical ultrasonic transducers.
AU693826B2 (en) Instrument for the penetration of body tissue
AU3228695A (en) Non-invasive blood analyte sensor
GB9223560D0 (en) Surgical/diagnostic aid
AU5864296A (en) Diagnostic imaging x-ray contrast agents
AU2990695A (en) Mucin-derived proteins for the diagnosis, imaging, and therapy of human cancer
AU2991697A (en) Methods of diagnosing clinical subtypes of crohn's disease
EP0771788A3 (en) Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them
AU2643292A (en) Biological tissue adhesion
AU5406198A (en) A breath test for the diagnosis of bacterial infection
AU3357597A (en) Skin blood flow measurement
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU5103096A (en) Use of ferrites for determining the perfusion of human tissue by m.r. diagnosis
AU1820499A (en) Compounds and methods for the diagnosis and treatment of (b. microti) infection
AU6592896A (en) Analysis of alpha integrins for the diagnosis of diabetic nephropathy
AU2371397A (en) Substituted 1-naphthoylguanidines, process for their preparation, their use as medicament or diagnostic, and medicament containing them
AU4670696A (en) Diagnosis of toxicoinfectious clostridiosis
AU6509698A (en) Methods for clinical diagnosis
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU7143996A (en) Method for the diagnosis of coeliac disease
AU3212099A (en) Method for increasing the permeability of horny human tissue
EP1136088B8 (en) Medical pressure transducer with sliding components